AI assistant
Sending…
ClearPoint Neuro, Inc. — Director's Dealing 2019
Sep 3, 2019
32641_dirs_2019-09-03_234b62ed-422a-488f-8a44-3649d4827358.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MRI INTERVENTIONS, INC. (MRIC)
CIK: 0001285550
Period of Report: 2019-09-01
Reporting Person: JOHNSON B KRISTINE (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-01 | Stock Option (right to buy) | $3.92 | A | 15000 | Acquired | 2029-09-01 | Common Stock (15000) | Direct |
Footnotes
F1: The shares subject to this option vest ratably on the first, second and third anniversaries of the grant date, September 1, 2020, September 1, 2021 and September 1, 2022.
More from ClearPoint Neuro, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19